Myeloproliferative neoplasms trials in Hong Kong

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

  Where

  Hksar

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06351631 · EU 2023-506996-89-00
• Phase 2Taking people
  Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis

  Where

  Hong Kong

  Age

  18 years and over

  People

  20

  Run by

  The University of Hong Kong

  See details and how to joinNCT06770842
• No phaseTaking people
  Asian Myeloproliferative Neoplasm (MPN) Registry

  Where

  Hong Kong

  Age

  18 years and over

  People

  1,000

  Run by

  The University of Hong Kong

  See details and how to joinNCT05882773